Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspase 6 | 12 | 2021 | 17 | 4.690 |
Why?
|
| Caspase 9 | 8 | 2021 | 22 | 3.390 |
Why?
|
| Zika Virus | 5 | 2025 | 36 | 3.190 |
Why?
|
| Viral Nonstructural Proteins | 6 | 2025 | 95 | 2.700 |
Why?
|
| Caspase 3 | 9 | 2021 | 108 | 2.590 |
Why?
|
| Caspases | 9 | 2021 | 176 | 2.550 |
Why?
|
| Caspase 7 | 8 | 2019 | 18 | 2.260 |
Why?
|
| Serine Endopeptidases | 4 | 2025 | 121 | 2.050 |
Why?
|
| Green Fluorescent Proteins | 7 | 2020 | 375 | 1.780 |
Why?
|
| Protease Inhibitors | 4 | 2025 | 106 | 1.770 |
Why?
|
| Apoptosis | 12 | 2021 | 1095 | 1.690 |
Why?
|
| Zika Virus Infection | 3 | 2025 | 37 | 1.590 |
Why?
|
| Models, Molecular | 20 | 2019 | 1160 | 1.500 |
Why?
|
| Allosteric Site | 6 | 2014 | 31 | 1.360 |
Why?
|
| Fluorescent Dyes | 3 | 2025 | 203 | 1.350 |
Why?
|
| Mutation, Missense | 5 | 2018 | 185 | 1.270 |
Why?
|
| Proteolysis | 6 | 2018 | 149 | 1.250 |
Why?
|
| Zinc | 3 | 2018 | 93 | 1.250 |
Why?
|
| Protein Conformation | 14 | 2025 | 785 | 1.180 |
Why?
|
| Protein Structure, Secondary | 10 | 2017 | 260 | 1.090 |
Why?
|
| Peptides | 4 | 2025 | 590 | 1.060 |
Why?
|
| Flavivirus | 2 | 2024 | 8 | 1.000 |
Why?
|
| Dengue Virus | 3 | 2020 | 99 | 0.990 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 283 | 0.980 |
Why?
|
| Cysteine | 2 | 2018 | 108 | 0.960 |
Why?
|
| Cysteine Endopeptidases | 2 | 2025 | 97 | 0.940 |
Why?
|
| Chikungunya virus | 1 | 2025 | 3 | 0.910 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2024 | 81 | 0.890 |
Why?
|
| Catalytic Domain | 9 | 2024 | 205 | 0.880 |
Why?
|
| Protein Binding | 12 | 2025 | 1619 | 0.880 |
Why?
|
| Protein Engineering | 4 | 2016 | 85 | 0.870 |
Why?
|
| Serine | 2 | 2016 | 91 | 0.860 |
Why?
|
| Molecular Probes | 2 | 2013 | 31 | 0.800 |
Why?
|
| Peptide Hydrolases | 3 | 2024 | 80 | 0.800 |
Why?
|
| Neoplasms | 3 | 2018 | 1393 | 0.770 |
Why?
|
| Allosteric Regulation | 7 | 2025 | 72 | 0.750 |
Why?
|
| Disulfides | 3 | 2018 | 66 | 0.720 |
Why?
|
| Crystallography, X-Ray | 8 | 2017 | 436 | 0.700 |
Why?
|
| Caspase Inhibitors | 5 | 2014 | 21 | 0.680 |
Why?
|
| Amino Acid Sequence | 11 | 2021 | 1597 | 0.670 |
Why?
|
| Binding Sites | 9 | 2019 | 914 | 0.650 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 202 | 0.630 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 123 | 0.630 |
Why?
|
| Amino Acid Substitution | 6 | 2018 | 239 | 0.620 |
Why?
|
| Humans | 37 | 2025 | 64272 | 0.600 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2018 | 5 | 0.580 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 147 | 0.580 |
Why?
|
| Protein Folding | 2 | 2018 | 268 | 0.580 |
Why?
|
| Autophagy-Related Proteins | 1 | 2018 | 16 | 0.580 |
Why?
|
| Genes, Reporter | 3 | 2020 | 260 | 0.570 |
Why?
|
| Directed Molecular Evolution | 2 | 2016 | 10 | 0.570 |
Why?
|
| Enzyme Activation | 5 | 2021 | 386 | 0.570 |
Why?
|
| Caspase Activation and Recruitment Domain | 1 | 2018 | 2 | 0.570 |
Why?
|
| Protein Multimerization | 3 | 2018 | 182 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2017 | 6 | 0.550 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 94 | 0.530 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 6 | 0.520 |
Why?
|
| Proteins | 6 | 2021 | 760 | 0.510 |
Why?
|
| Enzyme Assays | 2 | 2013 | 15 | 0.490 |
Why?
|
| Fluorescence | 2 | 2020 | 91 | 0.420 |
Why?
|
| Phosphorylation | 4 | 2018 | 948 | 0.410 |
Why?
|
| Substrate Specificity | 4 | 2025 | 340 | 0.390 |
Why?
|
| Kinetics | 6 | 2020 | 766 | 0.370 |
Why?
|
| Escherichia coli | 5 | 2021 | 718 | 0.370 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2012 | 8 | 0.370 |
Why?
|
| Proline | 1 | 2012 | 49 | 0.360 |
Why?
|
| Protein Kinases | 1 | 2012 | 153 | 0.340 |
Why?
|
| Nanocapsules | 3 | 2017 | 21 | 0.340 |
Why?
|
| Antiviral Agents | 1 | 2013 | 329 | 0.330 |
Why?
|
| Repressor Proteins | 1 | 2012 | 348 | 0.320 |
Why?
|
| Peptide Library | 1 | 2009 | 37 | 0.300 |
Why?
|
| Enzyme Stability | 3 | 2017 | 47 | 0.300 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1999 | 0.300 |
Why?
|
| Nanoparticles | 3 | 2021 | 523 | 0.270 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 495 | 0.270 |
Why?
|
| Protein Domains | 2 | 2018 | 154 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 674 | 0.250 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2025 | 41 | 0.240 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 705 | 0.240 |
Why?
|
| Mutation | 5 | 2016 | 2633 | 0.230 |
Why?
|
| Chikungunya Fever | 1 | 2025 | 4 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2025 | 129 | 0.230 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 34 | 0.220 |
Why?
|
| Cytosol | 2 | 2017 | 181 | 0.220 |
Why?
|
| Protons | 2 | 2017 | 65 | 0.220 |
Why?
|
| Enzymes | 1 | 2004 | 35 | 0.220 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 100 | 0.210 |
Why?
|
| Models, Chemical | 1 | 2004 | 140 | 0.210 |
Why?
|
| Catalysis | 3 | 2011 | 164 | 0.210 |
Why?
|
| Caspase 8 | 2 | 2021 | 65 | 0.210 |
Why?
|
| Drug Carriers | 2 | 2017 | 181 | 0.200 |
Why?
|
| Jurkat Cells | 3 | 2021 | 110 | 0.200 |
Why?
|
| Endosomes | 2 | 2021 | 177 | 0.180 |
Why?
|
| Salmonella | 1 | 2021 | 44 | 0.170 |
Why?
|
| Pancreatic Polypeptide | 2 | 2012 | 10 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 230 | 0.170 |
Why?
|
| Gels | 2 | 2017 | 74 | 0.170 |
Why?
|
| Protein Stability | 2 | 2012 | 92 | 0.160 |
Why?
|
| Flavivirus Infections | 1 | 2020 | 4 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 181 | 0.160 |
Why?
|
| Enzyme Precursors | 1 | 2019 | 11 | 0.150 |
Why?
|
| Nanopores | 1 | 2019 | 14 | 0.150 |
Why?
|
| Models, Biological | 1 | 2004 | 1187 | 0.150 |
Why?
|
| Porins | 1 | 2019 | 62 | 0.150 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2018 | 4 | 0.150 |
Why?
|
| Pliability | 1 | 2018 | 6 | 0.150 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2018 | 10 | 0.150 |
Why?
|
| Sulfones | 1 | 2018 | 41 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 374 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 306 | 0.150 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 123 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2018 | 147 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1494 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 328 | 0.140 |
Why?
|
| Arginine | 1 | 2018 | 131 | 0.140 |
Why?
|
| Phosphotransferases | 1 | 2017 | 23 | 0.140 |
Why?
|
| ErbB Receptors | 1 | 2018 | 118 | 0.140 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2017 | 19 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 298 | 0.130 |
Why?
|
| Tyrosine | 1 | 2017 | 94 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2021 | 3068 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 294 | 0.130 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 22 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2016 | 668 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1000 | 0.130 |
Why?
|
| Ligands | 3 | 2013 | 417 | 0.130 |
Why?
|
| Plasmids | 2 | 2021 | 293 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 67 | 0.130 |
Why?
|
| Animals | 7 | 2021 | 20955 | 0.130 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 275 | 0.130 |
Why?
|
| Polymers | 2 | 2021 | 327 | 0.130 |
Why?
|
| Lamins | 1 | 2016 | 5 | 0.120 |
Why?
|
| Biological Products | 1 | 2017 | 100 | 0.120 |
Why?
|
| Lipids | 1 | 2017 | 319 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 327 | 0.110 |
Why?
|
| Proteome | 1 | 2016 | 155 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 695 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2015 | 103 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 402 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 344 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2014 | 133 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 80 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2014 | 98 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2013 | 108 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2013 | 190 | 0.100 |
Why?
|
| Thrombin | 1 | 2012 | 22 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 92 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2012 | 29 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 113 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2013 | 105 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 303 | 0.090 |
Why?
|
| Molecular Mimicry | 1 | 2012 | 31 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 268 | 0.090 |
Why?
|
| Aminoisobutyric Acids | 1 | 2012 | 9 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 68 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 614 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 66 | 0.090 |
Why?
|
| Apoenzymes | 1 | 2011 | 4 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 100 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 749 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 417 | 0.080 |
Why?
|
| Protein Transport | 1 | 2012 | 405 | 0.080 |
Why?
|
| HeLa Cells | 3 | 2017 | 542 | 0.080 |
Why?
|
| Computational Biology | 1 | 2012 | 357 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2015 | 386 | 0.080 |
Why?
|
| Temperament | 1 | 2009 | 19 | 0.080 |
Why?
|
| Protein Denaturation | 1 | 2009 | 67 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2009 | 17 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2009 | 70 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 302 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 386 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2009 | 266 | 0.070 |
Why?
|
| Cell Death | 2 | 2020 | 286 | 0.060 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 272 | 0.060 |
Why?
|
| Dimerization | 1 | 2004 | 146 | 0.050 |
Why?
|
| Amides | 1 | 2004 | 56 | 0.050 |
Why?
|
| Mice | 2 | 2021 | 10994 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2009 | 887 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 373 | 0.050 |
Why?
|
| Colorimetry | 1 | 2022 | 26 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 370 | 0.050 |
Why?
|
| Bacteriolysis | 1 | 2021 | 6 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 132 | 0.040 |
Why?
|
| Salmonella typhimurium | 1 | 2021 | 86 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 153 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 59 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 2017 | 18 | 0.030 |
Why?
|
| Polymerization | 1 | 2017 | 36 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 56 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 86 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 102 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 107 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 138 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 141 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 207 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2057 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 498 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 142 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 133 | 0.030 |
Why?
|
| Drug Stability | 1 | 2015 | 144 | 0.030 |
Why?
|
| Emulsions | 1 | 2017 | 486 | 0.030 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 5 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2012 | 8 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2012 | 47 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 279 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 467 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1029 | 0.020 |
Why?
|
| Male | 1 | 2021 | 30322 | 0.010 |
Why?
|
| Female | 1 | 2021 | 33383 | 0.010 |
Why?
|